전문가Insight
home > 전문가 컨설팅> 전문가Insight
- 글자크기
Good Manufacturing Practices complementary to Experimental Drugs(ANVISA- BRAZIL)
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2020-01-20 | 조회수 | 5,146 |
| 원문 | 한국보건산업진흥원 | ||
| 출처 | |||
| Priscilla.png | |||
| 첨부파일 | |||
Good Manufacturing Practices Complementary to Experimental Drugs.pdf(120.28KB)-원문제목 : Guide for Good Manufacturing Practices complementary to Experimental Drugs, according to ANVISA- BRAZIL
-Abstract : This Normative Instruction is intended to adopt the Good Practice Guidelines for the Manufacturing of Experimental Drugs from the Pharmaceutical Inspection Cooperation Scheme, PIC/S, as complementary requirements to be followed in the manufacture of experimental drugs in addition to the General Good Practice Guidelines for Drug Manufacturing.
* 첨부파일 참고 바랍니다.
- 이전글 Good Practices on Drug Distribution, Storage and Transportation(ANVISA- BRAZIL)
- 다음글 Guide for the registration of active pharmaceutical ingredients (API), according to ANVISA- BRAZIL
댓글등록
로그인 후 작성 가능합니다.
0/250
